Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,582
Closed -$14.6K 1204
2025
Q1
$14.6K Buy
1,582
+980
+163% +$8.57K ﹤0.01% 1020
2024
Q4
$4.71K Buy
602
+490
+438% +$4.04K ﹤0.01% 866
2024
Q3
$829 Buy
+112
New +$942 ﹤0.01% 1030

Other funds holding ETNB

Aster Capital Management's ETNB Position: Q2 2025 in Review

Aster Capital Management sold out of 89bio (ETNB) in Q2 2025, closing a stake of 1,582 shares — an estimated $14.6K sold.

Aster Capital Management first reported a position in ETNB in Q3 2024 and held it in 3 quarters. The position peaked at $14.6K in Q1 2025. 184 funds tracked by Wall St. Rank hold ETNB as of Q2 2025.

  • Aster Capital Management reported no remaining 89bio position as of Q2 2025 after selling out during the quarter.
  • Aster Capital Management sold 1,582 89bio shares in Q2 2025, an estimated $14.6K.
  • Aster Capital Management first reported a position in 89bio in Q3 2024 and held it in 3 quarters.
  • Aster Capital Management's 89bio position peaked at $14.6K in Q1 2025.
  • 184 funds tracked by Wall St. Rank held 89bio as of Q2 2025.

Based on Aster Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.